Asset vs asset
NEXO is a NEXO market beta asset with $906.94M in market cap, while Injective is a INJ market beta asset with $303.19M. The useful comparison is market role, liquidity, seven-day direction, and which follow-up page gives the cleaner next decision.
Comparison Table
| Question | NEXO | Injective |
|---|---|---|
| Market role | NEXO market beta asset | INJ market beta asset |
| Price | $0.906939 | $3.03 |
| Market cap | $906.94M | $303.19M |
| 24h volume | $8.96M | $38.31M |
| 7d change | -0.16% | -1.11% |
| Relative size | NEXO is 2.99x Injective's market cap | Injective is 0.33x NEXO's market cap |
| Volume comparison | NEXO trades at 0.23x Injective's 24h volume | Injective trades at 4.27x NEXO's 24h volume |
Use the market-cap calculator when the real question is what one asset would imply at another size.
Open calculatorA cleaner comparison still needs a practical plan for exchanges, withdrawals, and wallets.
Open checklistPut both names back into the wider market context before treating the comparison as a final answer.
Open markets